CIBC Private Wealth Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.89K Hold
73
﹤0.01% 2736
2025
Q3
$2.57K Hold
73
﹤0.01% 2692
2025
Q2
$2.39K Hold
73
﹤0.01% 2597
2025
Q1
$2.23K Hold
73
﹤0.01% 2657
2024
Q4
$2.46K Sell
73
-55
-43% -$1.77K ﹤0.01% 2658
2024
Q3
$3.59K Sell
128
-44
-26% -$1.08K ﹤0.01% 2692
2024
Q2
$3.76K Buy
172
+44
+34% +$1.02K ﹤0.01% 2602
2024
Q1
$3.72K Buy
+128
New +$4.29K ﹤0.01% 2584
2018
Q3
Sell
-455
Closed -$12K 1022
2018
Q2
$12K Hold
455
﹤0.01% 1511
2018
Q1
$9K Hold
455
﹤0.01% 1549
2017
Q4
$8K Buy
+455
New +$9.01K ﹤0.01% 1596

Other funds holding ATRC

CIBC Private Wealth Group's ATRC Position: Q4 2025 in Review

CIBC Private Wealth Group held its AtriCure (ATRC) position steady in Q4 2025 at 73 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

CIBC Private Wealth Group first reported a position in ATRC in Q4 2017 and has held it in 11 quarters since. The position peaked at $12K in Q2 2018. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.

  • CIBC Private Wealth Group held 73 shares of AtriCure worth $2.89K as of Q4 2025.
  • CIBC Private Wealth Group left its AtriCure share count unchanged in Q4 2025.
  • AtriCure made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2736 holding.
  • CIBC Private Wealth Group first reported a position in AtriCure in Q4 2017 and has held it in 11 quarters since.
  • CIBC Private Wealth Group's AtriCure position peaked at $12K in Q2 2018.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.